Terms: = Breast cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Clinical Outcome
5 results:
1. breast tumor microenvironment structures are associated with genomic features and clinical outcome.
Danenberg E; Bardwell H; Zanotelli VRT; Provenzano E; Chin SF; Rueda OM; Green A; Rakha E; Aparicio S; Ellis IO; Bodenmiller B; Caldas C; Ali HR
Nat Genet; 2022 May; 54(5):660-669. PubMed ID: 35437329
[TBL] [Abstract] [Full Text] [Related]
2. Tumor cell intrinsic and extrinsic features predict prognosis in estrogen receptor positive breast cancer.
Yao K; Schaafsma E; Zhang B; Cheng C
PLoS Comput Biol; 2022 Mar; 18(3):e1009495. PubMed ID: 35263321
[TBL] [Abstract] [Full Text] [Related]
3. Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression.
Templeton AJ; Gonzalez LD; Vera-Badillo FE; Tibau A; Goldstein R; Šeruga B; Srikanthan A; Pandiella A; Amir E; Ocana A
PLoS One; 2016; 11(5):e0154789. PubMed ID: 27149669
[TBL] [Abstract] [Full Text] [Related]
4. A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
Absenger G; Szkandera J; Stotz M; Pichler M; Winder T; Langsenlehner T; Langsenlehner U; Samonigg H; Renner W; Gerger A
Mol Carcinog; 2013 Nov; 52 Suppl 1():E96-102. PubMed ID: 23625573
[TBL] [Abstract] [Full Text] [Related]
5. Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study.
Mieog JS; Morden JP; Bliss JM; Coombes RC; van de Velde CJ;
Lancet Oncol; 2012 Apr; 13(4):420-32. PubMed ID: 22265698
[TBL] [Abstract] [Full Text] [Related]
